Pacific RxTracts - February 2026

Authors

Pacific RxTracts

Files

Description

Articles:

• Reducing Proteinuria – FDA Accelerates Approval of Sibeprenlimab
• FDA Approves Oral Semaglutide as First GLP-1 Pill for Weight Loss
• New First-Line Digital Treatment for Generalized Anxiety Disorder
• Ammoxetine: A Potential New Antidepressant For Major Depressive
• Extended-Release Buprenorphine Dosing in Individuals With High-Risk Opioid Use
• Managing Acute Agitation Without Injections: Oral Medications in the ED
• Prescription Stimulant Continuation in Pregnancy and Birth Outcomes
• Zoliflodacin - A New Treatment For Gonorrhea
• Intranasal Dexmedetomidine for Postoperative Sleep Quality After Gynecologic Laparoscopy
• FDA Approves Depemokimab, the First Twice-Yearly Biologic for Severe Eosinophilic Asthma Cancer Care
• Engineering Allogeneic CD7-Targeted CAR-T Cells Through Targeted Base Editing
• Implications of GLP-1 and SGLT-2 Therapy on Frailty
• Incretin-Based Therapy for AUD
• A Promising Relief from Prurigo Nodularis
• Developing Therapy for Transthyretin Amyloidosis with Cardiomyopathy
• Biomarker-Guided Cardioprotection During Anthracycline Therapy
• Evolocumab in Patients without a Previous Myocardial Infarction or Stroke
• A New Option for oHCM: FDA Approval of Aficamten
• Etripamil Nasal Spray: Evidence-Based Self-Treatment for PSVT Conversion

Publication Date

2-2-2026

Volume

23

Issue

4

Pages

12

Publisher

University of the Pacific

City

Stockton, CA

Disciplines

Medicine and Health Sciences | Pharmacy and Pharmaceutical Sciences

Recommended Citation

Pacific RxTracts, "Pacific RxTracts - February 2026" (2026). Pacific RxTracts. 13.
https://scholarlycommons.pacific.edu/rx-tracts/13